ClinicalTrials.gg
CompletedNCT07768319Updated Aug 25, 2026

The Effectiveness of Online Group Dialectical Behavioral Therapy on Bulimia Nervosa

An interventional study of Online Group Dialectical Behavioral Therapy and Face-to-face Group Dialectical Behavioral Therapy in Bulimia Nervosa, sponsored by Shanghai Mental Health Center. Completed at 1 site in China. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Shanghai Mental Health Center · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Dec 2020, registered Aug 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

Bulimia Nervosa (BN) is a kind of chronic refractory mental disorder with high prevalence and relapse rate, which would cause serious damage to physical and mental health. Dialectical Behavioral Therapy (DBT) is an internationally effective and evidence-based therapy for BN patients. Previous studies have found that DBT group therapy can significantly improve the core symptoms of BN patients. Our research group has conducted DBT group therapy for BN, and found that after 12 weeks of treatment, the frequencies of binge eating and purging behavior of BN patients were significantly reduced. However, with the high cost of ground-based group therapy and low coverage, it is difficult to promote the G-DBT(Group Dialectical Behavioral Therapy) for BN, considering the shortage of mental health resource in China. Besides, videoconferencing-based psychotherapy has gradually emerged in recent years. However, there is still a lack of clinical studies on the videoconferencing-based G-DBT for BN at home and abroad to confirm its efficacy and feasibility. Therefore, this study intends to use a randomized controlled study by randomly allocating BN patients into videoconferencing-based G-DBT group and traditional G-DBT group for 12 weeks. By comparing the changes of core symptoms and psychological characteristics of BN patients before and after treatment, this study aims to illustrate the efficacy and feasibility of videoconferencing-based G-DBT is no less than traditional G-DBT.

02

Conditions studied

  • Bulimia Nervosa

Browse trials for

03

In context

Bulimia Nervosa

173 studies on the registry are indexed under Bulimia Nervosa; 39 are open to participants now.

This study's enrollment of 120 is above the median of 60 across 121 interventional studies indexed under Bulimia Nervosa.

Browse Bulimia Nervosa studies →

Lead sponsor

Shanghai Mental Health Center is the lead sponsor of 272 studies on the registry; 91 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female, 18-35 years old, right-handed;
  • Education level is junior high school or above;
  • Meet the Diagnostic criteria of Bulimia Nervosa in (The diagnostic and statistical manual of mental disorders,DSM), (BMI)≥18.5 kg/m2;
  • Did not receive systematic nutritional therapy, psychiatric drug therapy or any form of psychological therapy within 1 month before enrollment;
  • Able to understand the study and agree to participate.

Exclusion criteria

Exclusion Criteria:

  • Those who meet other diagnoses besides BN, such as substance abuse/dependence, depression, bipolar disorder, anxiety disorder, obsessive-compulsive disorder, etc. And those with high risk of suicide, strong disruptive impulse or antisocial behavior.
  • Patients with serious primary or secondary physical disease, cognitive impairment, so that they can not complete the required assessment.
  • Have received systematic nutritional therapy, individual and group psychotherapy previously.
  • Have taken neuroblockers, antidepressants, lithium salts, stimulants, antiepileptic drugs and other psychotropic drugs within the past 1 month.
  • For other reasons that researchers consider it inappropriate to participate in this clinical trial.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Experimental
    online G-DBT

    Participants receive the G-DBT via videoconference weekly.

    Behavioral: Online Group Dialectical Behavioral Therapy

  • Active comparator
    face-to-face G-DBT

    Participants attend the traditional G-DBT weekly in Shanghai Mental Health Center.

    Behavioral: Face-to-face Group Dialectical Behavioral Therapy

Interventions

  • BehavioralOnline Group Dialectical Behavioral Therapy

    Online G-DBT is an adapted version of G-DBT delivered via video-conference. The specific design of G-DBT is the same as traditional face-to-face G-DBT. It also consists of 12 sessions, which is conducted weekly and lasts for 120 minutes. There are two therapists in charge of the therapy.

    Also known as: Online G-DBT

  • BehavioralFace-to-face Group Dialectical Behavioral Therapy

    The G-DBT consists of 12 sessions, each lasting 120 minutes, and is held once a week. Two DBT therapists lead the patients to learn mindfulness skills, emotion regulation skills, pain tolerance skills, and interpersonal effectiveness skills. The aim is to help the patients reduce binge eating and harmful behaviors by regulating their emotions. Each sessions is conducted in a face-to-face way, in the psychological therapy room of the outpatient clinic in Shanghai Mental Health Center.

    Also known as: Face-to-face G-DBT

06

What researchers measure

Primary outcomes

  1. Changes of binge eating and purging episodes from baseline

    Measured by Eating Disorder Examination Questionnaire (EDE-Q, item 13 and 15). Core pathological behaviors of BN patients.

    Time frame: Baseline, week 12 (end of the treatment), week 16 and week 24

Secondary outcomes

  1. Change of disordered eating from baseline

    Measured by the total scores of EDE-Q and scores of its four subscales.

    Time frame: Baseline, week 12 (end of the treatment), week 16 and week 24

  2. Changes of eating disorder related cognitive and behavioral characteristics

    Measured by EDI(Eating Disorder Inventory), which consists of 8 subscales, 91 items.

    Time frame: Baseline, week 12 (end of the treatment), week 16 and week 24

  3. Change of impulse control ability

    Measured by Barratt Impulsiveness Scale Version 11 (BIS-11), which consists of 3 dimension, 26 items. Higher scores represent stronger impulse.

    Time frame: Baseline, week 12 (end of the treatment), week 16 and week 24

  4. Change of depression level

    Measured by Beck Depression Inventory (BDI-II), of which higher scores show deeper depression.

    Time frame: Baseline, week 12 (end of the treatment), week 16 and week 24

  5. Change of anxiety level

    Measured by Beck Anxiety Inventory (BAI). Higher scores show deeper anxiety.

    Time frame: Baseline, week 12 (end of the treatment), week 16 and week 24

  6. Change of emotion regulation ability

    Measured by Difficulties in Emotion Regulation Scale (DERS-16), which includes 16 items that falls into 5 factors.

    Time frame: Baseline, week 12 (end of the treatment), week 16 and week 24

07

Study locations

1 site
  • Shanghai Mental Health Center
    Shanghai, 200030, China
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Dec 2020 to primary completion in Nov 2022, 23 months.

Of 63 non-industry interventional studies with no phase under Bulimia Nervosa, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 58. This study's 23 months is below that.

Counting every sponsor, half of 65 studies reached it within 43 months; a quarter within 18 and three quarters within 49.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2022
First posted
Aug 17, 2026
StartActual
Dec 1, 2020
Primary completionActual
Nov 30, 2022
CompletionActual
Nov 30, 2023
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07768319
Collaborators
Shanghai Municipal Science and Technology Commission
Responsible party
Jue CHEN (Chief Physician, Department Director, Shanghai Mental Health Center) — Principal investigator
First posted
Aug 17, 2026
Start date
Dec 1, 2020
Primary completion
Nov 30, 2022
Completion
Nov 30, 2023
Last update
Aug 25, 2026

Study contacts

Jue Chen, PhD
principal investigator · Shanghai Mental Health Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion